Jpmorgan Chase & CO BIOGEN INC Call Options Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Call Options

11 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 10, 2024
SELL
N/A
-17,000 Reduced 47.22%
19,000 $0
Q4 2023

Feb 12, 2024
SELL
N/A
-8,700 Reduced 19.46%
36,000 $0
Q3 2023

Nov 14, 2023
BUY
N/A
37,200 Added 496.0%
44,700 $0
Q2 2023

Aug 11, 2023
SELL
N/A
-6,100 Reduced 44.85%
7,500 $0
Q1 2023

May 11, 2023
SELL
N/A
-92,700 Reduced 87.21%
13,600 $0
Q4 2022

Feb 13, 2023
SELL
N/A
-145,400 Reduced 57.77%
106,300 $29.4 Million
Q3 2022

Nov 14, 2022
BUY
N/A
59,000 Added 30.62%
251,700 $67.2 Million
Q2 2022

Aug 11, 2022
BUY
N/A
82,500 Added 74.86%
192,700 $39.3 Million
Q1 2022

May 11, 2022
SELL
N/A
-9,100 Reduced 7.63%
110,200 $23.2 Million
Q4 2021

Feb 10, 2022
BUY
N/A
109,800 Added 1155.79%
119,300 $28.6 Million
Q3 2021

Nov 12, 2021
BUY
N/A
9,500 New
9,500 $2.69 Million
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email